Left ventricular diastolic dysfunction of the left ventricle in glomerulopathies

  • Authors: Aiypova D.A1, Beishebaeva N.A2, Kaliev R.R3
  • Affiliations:
    1. National Center for Cardiology and Therapy n.a. Academician Mirsaid Mirrakhimov of the Ministry of Healthcare of the Kyrgyz Republic
    2. National Center for Maternal and Child Health Protection of the Ministry of Healthcare of the Kyrgyz Republic
    3. Kyrgyz State Medical Academy n.a. I.K. Akhunbaev
  • Issue: No 3 (2017)
  • Pages: 30-34
  • Section: Articles
  • URL: https://journals.eco-vector.com/2075-3594/article/view/272657
  • ID: 272657

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Aim. To evaluate the diastolic function of the heart in various variants of GPs. Materials and Methods. 55 patients aged from 17 to 58 (mean age, 32.76±10.3) years with GPs were examined (32 men, 23 women). All patients underwent nephrobiopsy. IgA, IgG and IgM GPs were diagnosed. Results. In the majority of patients (78.1%), the onset of the disease was diagnosed at a young age over 17 years. Clinically, most often there was a nephrotic syndrome (65.4%), and in most cases - in men (72.2%). Systolic and diastolic blood pressure was 130.3±20.0 mm Hg and 83.2±13.06 mm Hg, respectively. According to the nature of the immune deposits in different morphological types of GPs, we divided them into three subgroups. Analysis of clinical data has revealed statistically significant differences between patient groups. Diastolic dysfunction (DD) was diagnosed in 36.4% of patients with Gps at the early stages of the disease, before the development of renal failure. Conclusion. Each third patient with GP in the onset of the disease without renal failure was diagnosed with left ventricular dysfunction. The most pronounced signs of violations of diastolic LV filling were detected in patients with IgM nephropathy, as evidenced by reliable intergroup differences.

Full Text

Restricted Access

About the authors

D. A Aiypova

National Center for Cardiology and Therapy n.a. Academician Mirsaid Mirrakhimov of the Ministry of Healthcare of the Kyrgyz Republic

Email: dinaralievna@gmail.com
Researcher at the Department of Nephrology

N. A Beishebaeva

National Center for Maternal and Child Health Protection of the Ministry of Healthcare of the Kyrgyz Republic

Email: beishebaevanasira@gmail.com
PhD in Medical Science, Head of Department of Nephrology

R. R Kaliev

Kyrgyz State Medical Academy n.a. I.K. Akhunbaev

Email: karys2002@mail.ru
Professor, Doctor of Medical Sciences, Professor at the Department of Faculty Therapy KSMA

References

  1. Калиев Р.Р., Миррахимов М.М. Проблемы нефрологической службы в Кыргызской Республике в начале XXI века. ЦАМЖ. 2008;14(6):458-464.
  2. Калиев Р.Р., Миррахимов М.М. Развитие нефрологии в Кыргызстане. ЦАМЖ 2007;13(1):25-28.
  3. Швецов М. Значение пункционной биопсии почки в нефрологии. Врач. 2002;6:29-31.
  4. Варшавский В.А., Голицына Е.П., Столяревич Е.С., Пальцева Е.М. Морфологические критерии прогрессирования хронических болезней почек. Нефрология. Национальное руководство. М., 2014.
  5. Rane S., Mutyal P., Dcunha N., Parkhi M., Jadhav M. Clin Diagn Res. Role of Immunofluorescence in Adult Onset Nephrotic Syndrome-A Study in a Tertiary Care Centre of Western India. 2017;11(5) :EC01-EC04.
  6. Schiele F. Renal dysfunction and coronary disease: a high-risk combination. J. Nephrol. 2009;22(1):39-45.
  7. Tsuruya K., Eriguchi M., Yamada S., Hirakata H., Kitazono T. Cardiorenal Syndrome in End-Stage Kidney Disease. Blood Purif. 2015;40(4):337-343.
  8. Ronco C., Haapio M., House A.A., Anavekar N., Bellomo R. Cardiorenal syndrome. J. Am. Coll. Cardiol. 2008;52:1527-1539.
  9. Roy G.C., Sutradhar S.R., Barua U.K. Datta N.C., Debnath C.R., Hoque M.M., Hossain A.S., Haider M.S., Das M. Cardiovascular complications of chronic renal failure - an updated review. Mymensingh Med. J. 2012;21:573-579.
  10. Paoletti E., Specchia C., Di Maio G., Bellino D., Damasio B., Cassottana P., Cannella G. The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysispatients: a 10 year survey. Nephrol. Dial. Transplant. 2004;19(7):1829-1834.
  11. Weiner D.E., Tighiouart H., Vlagopoulos P.T., Griffith J.L., Salem D.N., Levey A.S., Sarnak M.J. Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease. J. Am. Soc. Nephrol. 2005;16(6):1803-10
  12. Paoletti E., Bellino D., Gallina A.M., Amidone M., Cassottana P., Cannella G. Is left ventricular hypertrophy a powerful predictor of progression to dialysis in chronic kidney disease?Nephrol. Dial. Transplant. 2011;26(2):670-677.
  13. London G.M., Pannier B, Guerin A.P., Blacher J., Marchais S.J., Darne B., Metivier F., Adda H., Safar M.E. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J. Am. Soc. Nephrol 2001;12:2759-2767.
  14. Bravo-Jaimes K., Whittembury A., Santivanez V. High prevalence of cardiovascular disease in end-stage kidney disease patients ongoing hemodialysis in Peru: why should we care about It? International Journal of Nephrology. 2015;Article ID 568702:6 pages.
  15. Cai Q.Z., Lu X.Z., Lu Y., Wang AY.M. Longitudinal changes of cardiac structure and function in CKD (CASCADE Study). Journal of the American society of Nephrology. JASN. 2014;25(7):1599-1608.
  16. Zile M.R., Brutsaert D.L. New concepts in diastolic dysfunction and diastolic heart hailure: part i diagnosis, prognosis, and measurements of diastolic function circulation. 2002;105:1387-1393.
  17. Nagueh S.F., Smiseth O.A., Appleton C.P. ASE/EACVI GUIDELINES AND STANDARDS Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J. Am. Soc. Echocardiogr. 2016;29:277-314.
  18. Bruch C., Rothenburger M., Gotzmann M., Wichter T., Scheid H.H., Breithardt G., Gradaus R. Chronic kidney disease in patients with chronic heart failure-impact on intracardiac conduction, diastolic function and prognosis. Int. J. Cardiol. 2007;118(3):375-380.
  19. Li KL., Wang R.X., Dai M., Lu J., Xue J., Yang X.J. Antihypertensive treatment improves left ventricular diastolic function in patients with chronic kidney disease. Experimental and Therapeutic Medicine. 2015;9(5):1702-1708.
  20. De Bie M.K., Ajmone M.N., Gaasbeek A., Bax J.J., Groeneveld M., Gabreels B.A., Delgado V., Rabelink T.J., Schalij M.J., Jukema J.W. Left ventricular diastolic dysfunction in dialysis patients assessed by novel speckle tracking strain rate analysis: prevalence and determinants. Int. J. Nephrol. 2012;2012:963504.
  21. Kunz K., Dimitrov Y., Muller S., Chantrel F., Hannedouche T. Uraemic cardiomyopathy. Nephrol. Dial Transplant. 1998;13(4):39-43.
  22. Barberato S.H., Pecoits-Filho R. Echocardiographic alterations in patients with chronic kidney failure undergoing hemodialysis. Arq. Bras. Cardiol. 2010; 94(1):140-146.
  23. Nardi E., Cottone S., Mule G., Palermo A., Cusimano P., Cerasola G. Influence of chronic renal insufficiency on left ventricular diastolic function in hypertensives without left ventricular hypertrophy. J Nephrol. 2007;20(3):320-328.
  24. Abedini M., Sadeghi M., Naini A.E., Atapour A., Golshahi J. Pulmonary Hypertension among Patients on Dialysis and Kidney Transplant Recipients. Renal Failure. 2013;35(4):560-565.
  25. Higashi M., Yamaura K., Ikeda M., Ikeda M., Shimauchi T., Saiki H., Hoka S. Diastolic dysfunction of the left ventricle is associated with pulmonary edema after renal transplantation. Acta Anaesthesiologica Scandinavica. 2013;57(9):1154-1160.
  26. Jain A., Scott C., Chen H.H. The renal-cardiac connection in subjects with preserved ejection fraction: a population based study. ESC Heart Fail. 2017;4(3):266-273.
  27. National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am. J. Kidney Dis. 2002;39:S1-266.
  28. Thomson N.M., Charlesworth J. Classification, pathology and clinical features: Primary glomerulonephritis, in Textbook of Renal Disease (2nd ed.), Whitworth J., Lawrence J. (ed), Edinburgh. Churchill Livingstone. 1995,129-157.
  29. Острый гломерулонефрит - все ли вопросы решены? Клиническая нефрология. 2009;2:4-9.
  30. Хасабов Н.Н., Малкоч А.В. Современные представления о гломерулонефритах. Нефрология детского возраста. М.,2005;306-390.
  31. Kolarz M., Wyroslak J., Zbrog Z., Krasniak A., Rogulska J., Padjas A. Antibodies against N-homocysteinylated proteins and their determinants in patients on long-term hemodialysis. Pol. Arch. Med. Wewn. 2010;120:223-230.
  32. Bautista L., Vera L., Arenas I., Gamarra G. Independent association between inflammatory markers (C-reactiveprotein, interleukin-6, and TNF-a) and essential hypertension. J. Hum. Hypertens. 2005;19:149-154.
  33. Liverman P.C., Tucker F.L., Bolton W.K. Erythrocyte sedimentation rate in glomerular disease: association with urinary protein. Am. J. Nephrol. 1988;8:363.
  34. Rane S., Mutyal P., Dcunha N., Parkhi M., Jadhav. Role of Immunofluorescence in Adult Onset Nephrotic Syndrome-A Study in a Tertiary Care Centre of Western India. J. Clin. Diagn. Res. 2017;11(5):01-04.
  35. Berger J. IgA glomerular deposits in renal disease. Transplant. Proc. 1969;1:939-944,
  36. Bustos С., Gonzales E., Gonzales-Cuadrado S., Ortiz A., Muley R., de Nicolas R. Urinary excreation of platelet-activating factor in human and experimental nephrosis. Nephrol Dial. Transplant. 1996;11(2):282-286.
  37. McEnery P.T., Coutinho M.-J. Membranoproliferative glomerulonephritis. In: Holliday M.A., Barratt T.M., Avner E.D. (eds): Pediatric Nephrology. Baltimore: Williams and Wilkins. 1994;739-754.
  38. van Es L.A., de Heer E., Vleming L.J., van der Wal A., Mallat M., Bajema I. Bruijn J.A., de Fijter J.W. GMP-17-positive T-lymphocytes in renal tubules predict progression in early stages of IgA nephropathy. Kidney Int. 2008; 73:1426-1433.
  39. Haas M., Rahman M.H., Cohn R.A., Fathallah-Shaykh S., Ansari A., Bartosh S.M. IgA nephropathy in children and adults comparison of histologic features and clinical outcome. Nephrol. Dial. Transplant. 2008;23:2537-2545.
  40. Ермоленко В.М. Хроническая почечная недостаточность. М.,2000;596-698.
  41. Томилина Н.А., Бикбов Б.Т. Эпидемиология хронической почечной недостаточности и новые подходы к классификации и оценке тяжести хронических прогрессирующих заболеваний почек. Терапевтический архив. 2005;6.
  42. Мухин Н.А., Балкаров И.М., Моисеев С.В. Хронические прогрессирующие нефропатии и образ жизни современного человека. Тер.архив. 2004;9:5-11.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies